Green Cross (005250) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.074x

Based on the latest financial reports, Green Cross (005250) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩139.95 Billion ≈ $94.84 Million USD) by net assets (₩1.89 Trillion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 005250 net asset quality score to measure how much of total assets are equity-financed.

Green Cross - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Green Cross's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Green Cross (005250) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Green Cross Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Green Cross ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Vátryggingafélag Íslands hf
IC:SKAGI
0.083x
ABEONA THERAPEUT. DL-01
F:PCJ
-0.113x
Guangdong Tianhe Agricultural Means
SHE:002999
-0.233x
NACCO Industries Inc
NYSE:NC
0.028x
Phihong Technology Co Ltd
TW:2457
-0.063x
Beijing Dalong Weiye Real Estate Development Co Ltd
SHG:600159
-0.027x
Fujian Cement Inc
SHG:600802
-0.135x
HL Corp Shenzhen
SHE:002105
0.054x

Annual Cash Flow Conversion Efficiency for Green Cross (2000–2024)

The table below shows the annual cash flow conversion efficiency of Green Cross from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see 005250 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩1.85 Trillion
≈ $1.26 Billion
₩-89.95 Billion
≈ $-60.96 Million
-0.049x -130.42%
2023-12-31 ₩1.88 Trillion
≈ $1.28 Billion
₩-39.65 Billion
≈ $-26.87 Million
-0.021x -142.67%
2022-12-31 ₩1.97 Trillion
≈ $1.33 Billion
₩97.16 Billion
≈ $65.84 Million
0.049x -9.05%
2021-12-31 ₩1.91 Trillion
≈ $1.29 Billion
₩103.77 Billion
≈ $70.32 Million
0.054x +154.07%
2020-12-31 ₩1.67 Trillion
≈ $1.13 Billion
₩35.77 Billion
≈ $24.24 Million
0.021x +320.95%
2019-12-31 ₩1.51 Trillion
≈ $1.02 Billion
₩7.65 Billion
≈ $5.18 Million
0.005x -80.40%
2018-12-31 ₩1.45 Trillion
≈ $984.76 Million
₩37.64 Billion
≈ $25.51 Million
0.026x -74.19%
2017-12-31 ₩1.44 Trillion
≈ $975.64 Million
₩144.48 Billion
≈ $97.91 Million
0.100x +17256.99%
2016-12-31 ₩1.38 Trillion
≈ $933.18 Million
₩-805.47 Million
≈ $-545.86K
-0.001x -110.87%
2015-12-31 ₩1.31 Trillion
≈ $885.99 Million
₩7.04 Billion
≈ $4.77 Million
0.005x -88.35%
2014-12-31 ₩1.18 Trillion
≈ $800.39 Million
₩54.54 Billion
≈ $36.96 Million
0.046x +189.06%
2013-12-31 ₩1.10 Trillion
≈ $745.23 Million
₩17.57 Billion
≈ $11.91 Million
0.016x -57.76%
2012-12-31 ₩972.83 Billion
≈ $659.27 Million
₩36.80 Billion
≈ $24.94 Million
0.038x -70.84%
2011-12-31 ₩895.76 Billion
≈ $607.04 Million
₩116.18 Billion
≈ $78.73 Million
0.130x -69.37%
2010-12-31 ₩839.83 Billion
≈ $569.14 Million
₩355.62 Billion
≈ $241.00 Million
0.423x -54.13%
2009-12-31 ₩522.78 Billion
≈ $354.28 Million
₩482.60 Billion
≈ $327.05 Million
0.923x +93.20%
2008-12-31 ₩350.47 Billion
≈ $237.51 Million
₩167.47 Billion
≈ $113.49 Million
0.478x -36.16%
2007-12-31 ₩351.08 Billion
≈ $237.92 Million
₩262.77 Billion
≈ $178.07 Million
0.748x +59.53%
2006-12-31 ₩221.73 Billion
≈ $150.26 Million
₩104.03 Billion
≈ $70.50 Million
0.469x +78.48%
2005-12-31 ₩236.96 Billion
≈ $160.59 Million
₩62.29 Billion
≈ $42.22 Million
0.263x -69.80%
2003-12-31 ₩210.22 Billion
≈ $142.46 Million
₩182.96 Billion
≈ $123.99 Million
0.870x +648.32%
2001-12-31 ₩273.93 Billion
≈ $185.64 Million
₩31.86 Billion
≈ $21.59 Million
0.116x -39.13%
2000-12-31 ₩282.15 Billion
≈ $191.21 Million
₩53.91 Billion
≈ $36.53 Million
0.191x --

About Green Cross

KO:005250 Korea Biotechnology
Market Cap
$283.20 Million
₩417.89 Billion KRW
Market Cap Rank
#14991 Global
#473 in Korea
Share Price
₩9300.00
Change (1 day)
+2.09%
52-Week Range
₩9040.00 - ₩17170.00
All Time High
₩51630.05
About

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more